KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Shares Outstanding (Diluted Average) (2021 - 2025)

ClearPoint Neuro (CLPT) has disclosed Shares Outstanding (Diluted Average) for 8 consecutive years, with $28.3 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 4.76% to $28.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $28.3 million through Dec 2025, up 4.76% year-over-year, with the annual reading at $28.3 million for FY2025, 4.76% up from the prior year.
  • Shares Outstanding (Diluted Average) hit $28.3 million in Q4 2025 for ClearPoint Neuro, up from $28.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $28.3 million in Q4 2025 to a low of $18.9 million in Q1 2021.
  • Historically, Shares Outstanding (Diluted Average) has averaged $24.7 million across 5 years, with a median of $24.6 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): increased 25.62% in 2022 and later rose 0.41% in 2023.
  • Year by year, Shares Outstanding (Diluted Average) stood at $20.7 million in 2021, then increased by 16.63% to $24.2 million in 2022, then rose by 1.75% to $24.6 million in 2023, then increased by 9.85% to $27.0 million in 2024, then rose by 4.76% to $28.3 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for CLPT at $28.3 million in Q4 2025, $28.1 million in Q3 2025, and $28.3 million in Q2 2025.